CompletedPhase 1NCT01523002

Drug Interaction Study of Pyronaridine-artesunate & Metoprolol, & Redosing Study of Pyronaridine-artesunate

Studying Malaria

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Medicines for Malaria Venture
Principal Investigator
Rolf Pokorny, MD, MSc
Covance Research Unit AG
Intervention
Metoprolol and pyronaridine-artesunate(drug)
Enrollment
56 enrolled
Eligibility
18-55 years · All sexes
Timeline
2012 – 2012

Study locations (1)

Collaborators

Shin Poong Pharmaceuticals

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01523002 on ClinicalTrials.gov

Other trials for Malaria

Additional recruiting or active studies for the same condition.

See all trials for Malaria →

← Back to all trials